Here is a QUOTE that isn't totally correct it is m

Here is a QUOTE that isn't totally correct it is mis-leading in my opinion because Doc took PPSI UNIVEC'S Subsidiary for partially deferred Salary/Loans owed him

All filings are public going back to the beginning anyone if they want to take time can look at them. I'm not trying to cause trouble but everyone should look here is a small example because in my opinion Doc has been paid very well for his services one year it was over $400,000.00 he got paid not deferred

Here is one from June 2011 LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable and accrued expenses $ 1,138
Accrued payroll 1,937,091
Notes and loans payable - current 950,438
Loans payable - officers/directors 244,412
Due to affiliated companies 0
Total current liabilities 3,133,079

https://www.otcmarkets.com/otcapi/company/fin...66/content

Quote:

---

Few have actually looked at the old Edgar filings AND read the footnotes on the financials. (Have you ever heard "the most important information is in the footnotes." Also read the offering memorandum for going public on the top tier Nasdaq.

In the financials, footnotes, Doc, Univec, Inc bought PPSI in the late 90's if I remember correctly and it was loosing money. He later took PPSI and the syringe business out of Univec, Inc for payment of an $874,000 loan made from his HRI business to Univec, Inc. PPSI was still loosing money. He took them out just before he went dark. Completely legal, ethical and above board, Univec owed HRI the money and could not pay the loan

---

Quote:

---

Some postings here claim Doc has and is making money off his shareholders. I ask them to please point it out where this is happening. Answer they can't. Doc has never sold shares into the bid after a big press release and then pay himself a fat salary. If FACT he has never taken a nickle in salary out of Univec, Inc., not even when we were dollars on the Nasdaq, he always deferred his salary. Just look at the Edgar filings, read the footnotes

---

Univec 10KSB - SEC.govhttps://www.sec.gov › Archives › edgar › data › univec10...
On December 31, 2001 Univec, Inc., acquired Physician and Pharmaceutical. Services, Inc., (PPSI) a company engaged in group purchasing (GPO) and promoting


On December 31, 2001 Univec, Inc., acquired Physician and Pharmaceutical
Services, Inc., (PPSI) a company engaged in group purchasing (GPO) and promoting
Pharmaceutical company prescription samples to physicians for their patients. PPSI
reduces the cost in the prescription-sampling channel by providing efficient
fulfillment and tracking of prescription usage. PPSI's national network of pharmacies
fills the sample prescription on a discounted fee and the Company's mail service
fulfillment complements additional needs. PPSI's approach conforms to regulations
requiring increased accountability and elimination of diversion of prescription
samples, consequently reducing the exposure of physicians and pharmaceutical companies
to potential liabilities and non-compliance penalties. PPSI’s group purchasing programs
provide for reduces prices on prescription drugs and other products through leveraged
purchasing and closed system market share. Univec also is a distributor of a highly
regulated pharmaceutical drug, methadone and other prescription drug products.

Univec during late 2004 established the company as a distributor of specialty and
highly regulated pharmaceutical products. The company intends to expand the product line
to take further advantage of its group purchasing and closed systems purchasing.

Univec extended its product line to include a highly regulated pharmaceutical (methadone)
and other pharmaceutical products. The company will continue to sell it products through
large United States based wholesalers as well as direct in large bulk to the larger
customers of the company. The company’s group purchase programs and closed market purchasing
positions the company’s product line well